NEW YORK, NY (Oct. 24, 2016)—Patients who had a stent procedure or heart bypass surgery and continued with their prescribed medical therapy had significantly better outcomes than nonadherent patients, according to a study published today in the journal Circulation.
The study also found that adherence to medical therapy was a more powerful predictor of adverse event-free survival than the type of revascularization procedure a patient had.
“A great deal of clinical research has been devoted to comparing outcomes in people who have had bypass surgery or a stent,” said Paul Kurlansky, MD, assistant professor of surgery at Columbia University Medical Center, cardiac surgeon at NewYork-Presbyterian/Columbia, and associate director of Columbia’s Center for Innovation and Outcomes Research in the Department of Surgery. “But very few studies have looked at what happens to those outcomes when patients do not adhere to their prescribed medical therapy. This is particularly important because roughly one-quarter of revascularization patients eventually stop taking their medications, due to issues such as medication costs, side effects, and a lack of noticeable symptoms.”
In coronary artery bypass (CABG) surgery, blood flow to the heart is rerouted around blocked arteries, using one or more veins or arteries. In percutaneous coronary interventions (PCI), a catheter is threaded through an artery in the groin or wrist to deliver a stent or other medical therapy to the diseased vessel.
The study included 3,228 patients from eight community hospitals who underwent a revascularization procedure in 2004. Of these, 973 patients had bypass surgery and 2,255 patients had PCI. The researchers followed the participants for five to seven years after treatment, obtaining a detailed medication history and tabulating major adverse coronary events (MACE) for each group, including nonfatal heart attacks, repeat revascularization procedures, and death.
At the end of the follow-up period, those who had continued with their prescribed medical therapy were 2.8 times more likely to have survived without a major heart problem compared with those who were nonadherent.
There was no statistically significant difference in MACE-free survival between bypass and PCI patients who had continued with their medications, with more than 90 percent MACE-free survival in patients with similar clinical characteristics. However, nonadherent patients who had PCI were nearly one and a half times more likely than surgery patients to have a major cardiac event.
Optimal medical therapy after revascularization includes antiplatelet therapy (aspirin for bypass patients or one year of double-antiplatelet therapy for PCI patients) and lipid-lowering medications (statins) indefinitely to keep the coronary arteries from becoming clogged again.
“While larger, prospective studies are needed to replicate our results, this study underscores the importance of educating PCI and bypass patients about the need to stick to their prescribed regimens, even if they feel just fine,” said Dr. Kurlansky, lead author of the paper. “It also suggests that physicians may need to recommend surgery instead of PCI for patients who are unlikely to adhere to their prescribed medical therapy.”
The study, titled “CABG vs. PCI: Meds Matter, Impact of Adherence to Medical Therapy on Comparative Outcomes,” was funded by unrestricted educational grants from the Florida Heart Research Institute and HCA Healthcare.
Additional authors are Morley Herbert, PhD, and Syma Prince, RN, BSN of Medical City Dallas Hospital, Dallas, TX, and Michael J. Mack, MD, of The Heart Hospital, Baylor Plano, TX.
None of the authors report any conflicts of interest.
Columbia University Medical Center provides international leadership in basic, preclinical, and clinical research; medical and health sciences education; and patient care. The medical center trains future leaders and includes the dedicated work of many physicians, scientists, public health professionals, dentists, and nurses at the College of Physicians and Surgeons, the Mailman School of Public Health, the College of Dental Medicine, the School of Nursing, the biomedical departments of the Graduate School of Arts and Sciences, and allied research centers and institutions. Columbia University Medical Center is home to the largest medical research enterprise in New York City and State and one of the largest faculty medical practices in the Northeast. The campus that Columbia University Medical Center shares with its hospital partner, NewYork-Presbyterian, is now called the Columbia University Irving Medical Center. For more information, visit cumc.columbia.edu or columbiadoctors.org.
NewYork-Presbyterian is one of the nation’s most comprehensive healthcare delivery networks, focused on providing innovative and compassionate care to patients in the New York metropolitan area and throughout the globe. In collaboration with two renowned medical school partners, Weill Cornell Medicine and Columbia University College of Physicians & Surgeons, NewYork-Presbyterian is consistently recognized as a leader in medical education, groundbreaking research and clinical innovation.
NewYork-Presbyterian has four major divisions: NewYork-Presbyterian Hospital is ranked #1 in the New York metropolitan area by U.S. News and World Report and repeatedly named to the magazine’s Honor Roll of best hospitals in the nation; NewYork-Presbyterian Regional Hospital Network is comprised of leading hospitals in and around New York and delivers high-quality care to patients throughout the region; NewYork-Presbyterian Physician Services connects medical experts with patients in their communities; and NewYork-Presbyterian Community and Population Health features the hospital’s ambulatory care network sites and operations, community care initiatives and healthcare quality programs, including NewYork Quality Care, established by NewYork-Presbyterian, Weill Cornell and Columbia.
NewYork-Presbyterian is one of the largest healthcare providers in the U.S. Each year, nearly 29,000 NewYork-Presbyterian professionals deliver exceptional care to more than 2 million patients.
For more information, visit www.nyp.org and find us on Facebook, Twitter and YouTube.